ARGENX SE-ADR ROA 2017-2018 | ARGX

Current and historical return on assets (ROA) values for ARGENX SE-ADR (ARGX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ARGENX SE-ADR ROA for the three months ending December 31, 2018 was 0.00%.
ARGENX SE-ADR ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.616B $0.025B
argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.422B 12.15
Gilead Sciences (GILD) United States $86.782B 10.54
Celgene (CELG) United States $64.715B 10.96
Biogen (BIIB) United States $45.297B 8.60
Vertex Pharmaceuticals (VRTX) United States $45.172B 54.60
Illumina (ILMN) United States $44.437B 51.50
CSL (CSLLY) Australia $35.310B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.586B 15.32
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.590B 15.61
Incyte (INCY) United States $17.453B 70.77
BioMarin Pharmaceutical (BMRN) United States $15.040B 0.00
Exact Sciences (EXAS) United States $15.005B 0.00
SINO PHARMACEUT (SBMFF) China $14.407B 0.00
Sarepta Therapeutics (SRPT) United States $11.635B 0.00
Genmab (GNMSF) Denmark $11.067B 56.26
Array BioPharma (ARRY) United States $10.358B 0.00
Seattle Genetics (SGEN) United States $10.323B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $9.032B 29.67
Galapagos (GLPG) Belgium $8.749B 0.00
Guardant Health (GH) United States $8.099B 0.00
Bio-Techne Corp (TECH) United States $7.974B 54.41
Alnylam Pharmaceuticals (ALNY) United States $7.755B 0.00
Bluebird Bio (BLUE) United States $7.483B 0.00
Amarin (AMRN) Ireland $7.232B 0.00
Exelixis (EXEL) United States $6.464B 16.48
BeiGene (BGNE) Cayman Islands $5.733B 0.00
Ascendis Pharma (ASND) Denmark $4.717B 0.00
Moderna (MRNA) United States $4.711B 0.00
Blueprint Medicines (BPMC) United States $4.686B 0.00
Horizon Pharma Public (HZNP) Ireland $4.348B 11.20
Repligen (RGEN) United States $4.059B 101.12
ACADIA Pharmaceuticals (ACAD) United States $3.852B 0.00
Mirati Therapeutics (MRTX) United States $3.805B 0.00
Spark Therapeutics (ONCE) United States $3.765B 0.00
China Biologic Products (CBPO) China $3.689B 23.43
Alkermes (ALKS) Ireland $3.662B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.369B 0.00
MorphoSys AG (MOR) Germany $3.287B 0.00
Arena Pharmaceuticals (ARNA) United States $3.077B 6.25
Amicus Therapeutics (FOLD) United States $2.888B 0.00
Immunomedics (IMMU) United States $2.724B 0.00
Medicines (MDCO) United States $2.713B 0.00
UniQure (QURE) Netherlands $2.633B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.607B 0.00
Reata Pharmaceuticals (RETA) United States $2.582B 0.00
Halozyme Therapeutics (HALO) United States $2.461B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.328B 0.00
MyoKardia (MYOK) United States $2.314B 0.00
Ligand Pharmaceuticals (LGND) United States $2.291B 18.98
Emergent Biosolutions (EBS) United States $2.238B 19.44
Akcea Therapeutics (AKCA) United States $2.178B 0.00
Acceleron Pharma (XLRN) United States $2.159B 0.00
NeoGenomics (NEO) United States $2.133B 139.63
Genomic Health (GHDX) United States $2.121B 45.04
Zai Lab (ZLAB) China $2.116B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.064B 0.00
Denali Therapeutics (DNLI) United States $1.970B 0.00
Myriad Genetics (MYGN) United States $1.912B 19.02
REGENXBIO (RGNX) United States $1.759B 0.00
Insmed (INSM) United States $1.725B 0.00
Cambrex (CBM) United States $1.523B 19.25
AnaptysBio (ANAB) United States $1.504B 0.00
Fate Therapeutics (FATE) United States $1.443B 0.00
Innoviva (INVA) United States $1.428B 3.95
RA PHARMCTL INC (RARX) United States $1.404B 0.00
Sangamo Therapeutics (SGMO) United States $1.384B 0.00
Athenex (ATNX) United States $1.341B 0.00
Alector (ALEC) United States $1.309B 0.00
Coherus BioSciences (CHRS) United States $1.308B 0.00
Editas Medicine (EDIT) United States $1.245B 0.00
Epizyme (EPZM) United States $1.240B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.188B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.050B 0.00
Codexis (CDXS) United States $1.022B 0.00
Cara Therapeutics (CARA) United States $1.010B 0.00
Adverum Biotechnologies (ADVM) United States $0.986B 0.00
ANI Pharmaceuticals (ANIP) United States $0.973B 17.26
Dicerna Pharmaceuticals (DRNA) United States $0.970B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.950B 0.00
Principia Biopharma (PRNB) United States $0.945B 0.00
Twist Bioscience (TWST) United States $0.942B 0.00
Zymeworks (ZYME) Canada $0.936B 0.00
WAVE Life Sciences (WVE) Singapore $0.925B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.924B 0.00
Retrophin (RTRX) United States $0.879B 0.00
Vericel (VCEL) United States $0.861B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Arvinas (ARVN) United States $0.805B 0.00
Intellia Therapeutics (NTLA) United States $0.767B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.719B 33.92
Precision BioSciences (DTIL) United States $0.693B 0.00
Clovis Oncology (CLVS) United States $0.687B 0.00
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Zealand Pharma (ZEAL) Denmark $0.676B 7.90
Cellectis S.A (CLLS) France $0.654B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.646B 0.00
Cytokineticsorporated (CYTK) United States $0.639B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.631B 0.00
Intra-Cellular Therapies (ITCI) United States $0.630B 0.00
Heska (HSKA) United States $0.629B 64.40
DBV Technologies S.A (DBVT) France $0.621B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.575B 0.00
Anika Therapeutics (ANIK) United States $0.573B 19.58
MiMedx (MDXG) United States $0.561B 0.00
Revance Therapeutics (RVNC) United States $0.552B 0.00
Stemline Therapeutics (STML) United States $0.551B 0.00
CytomX Therapeutics (CTMX) United States $0.534B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.503B 0.00
PHARMA MAR SA (PHMMF) Spain $0.459B 0.00
UROGEN PHARMA (URGN) United States $0.446B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
Puma Biotechnology (PBYI) United States $0.433B 0.00
Gritstone Oncology (GRTS) United States $0.395B 0.00
Prothena (PRTA) Ireland $0.386B 0.00
Biofrontera AG (BFRA) Germany $0.385B 0.00
Scholar Rock Holding (SRRK) United States $0.376B 0.00
PDL BioPharma (PDLI) United States $0.373B 8.91
AC Immune SA (ACIU) Switzerland $0.372B 23.96
Arcus Biosciences (RCUS) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.366B 0.00
Bellus Health (BLUSF) Canada $0.359B 0.00
Merus (MRUS) Netherlands $0.358B 0.00
Avid Bioservices (CDMO) United States $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.350B 0.00
Albireo Pharma (ALBO) United States $0.347B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.343B 0.00
Prometic Life Sciences (PFSCD) Canada $0.341B 0.00
Agenus (AGEN) United States $0.341B 0.00
Senesco Technologies (ELOX) United States $0.338B 0.00
Starpharma Holdings (SPHRY) Australia $0.337B 0.00
Theratechnologies (THERF) Canada $0.330B 0.00
Kadmon Holdings (KDMN) United States $0.321B 0.00
Syros Pharmaceuticals (SYRS) United States $0.319B 0.00
Acorda Therapeutics (ACOR) United States $0.316B 5.56
AMAG Pharmaceuticals (AMAG) United States $0.312B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
Protagonist Therapeutics (PTGX) United States $0.308B 0.00
Kindred Biosciences (KIN) United States $0.305B 0.00
Inovio Pharmaceuticals (INO) United States $0.290B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.271B 0.00
Cellular Biomedicine (CBMG) United States $0.266B 0.00
PHASEBIO PHARMA (PHAS) United States $0.263B 0.00
Dynavax Technologies (DVAX) United States $0.263B 0.00
Sutro Biopharma (STRO) United States $0.262B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.243B 0.00
Kamada (KMDA) Israel $0.236B 9.16
Athersys (ATHX) United States $0.234B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Cel-Sci (CVM) United States $0.231B 0.00
Geron (GERN) United States $0.229B 0.00
Palatin Technologies (PTN) United States $0.226B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.210B 0.00
Synlogic (SYBX) United States $0.210B 0.00
Cerecor (CERC) United States $0.208B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
MannKind (MNKD) United States $0.205B 0.00
CorMedix Inc (CRMD) United States $0.204B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
Pfenex (PFNX) United States $0.197B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
POXEL SA FRANCE (PXXLF) $0.194B 0.00
Mersana Therapeutics (MRSN) United States $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.187B 0.00
Enzo Biochem (ENZ) United States $0.185B 0.00
Arsanis (XFOR) United States $0.184B 0.00
BioTime (BTX) United States $0.180B 12.00
Compugen (CGEN) Israel $0.177B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.163B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.160B 0.00
XOMA (XOMA) United States $0.159B 0.00
Strongbridge Biopharma (SBBP) United States $0.155B 8.94
Liquidia Technologies (LQDA) United States $0.146B 0.00
Cue Biopharma (CUE) United States $0.144B 0.00
OvaScience (MLND) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
Dyadic (DYAI) United States $0.138B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arbutus Biopharma (ABUS) Canada $0.133B 0.00
Aptinyx (APTX) United States $0.128B 0.00
Aduro Biotech (ADRO) United States $0.122B 0.00
Menlo Therapeutics (MNLO) United States $0.119B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.119B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.117B 0.00
Alcobra (ARCT) United States $0.117B 0.00
Seres Therapeutics (MCRB) United States $0.115B 0.00
Novavax (NVAX) United States $0.111B 0.00
NantKwest (NK) United States $0.111B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
Verastem (VSTM) United States $0.108B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.103B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
Fortress Biotech (FBIO) United States $0.099B 0.00
Trevena (TRVN) United States $0.098B 0.00
Checkpoint Therapeutics (CKPT) United States $0.098B 0.00
SESEN BIO, INC (SESN) United States $0.095B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
AquaBounty Technologies (AQB) United States $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.084B 0.00
Curis (CRIS) United States $0.082B 0.00
VBI Vaccines (VBIV) United States $0.080B 0.00
Pluristem Therapeutics (PSTI) Israel $0.078B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
Unum Therapeutics (UMRX) United States $0.069B 0.00
Orgenesis (ORGS) United States $0.067B 0.00
Signal Genetics (MGEN) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
ARAVIVE, INC (ARAV) United States $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Invo BioScience (IVOB) United States $0.059B 0.00
Antibe Therapeutics (ATBPF) Canada $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.052B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00